drugset / Trial / NCT00082576
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | — |
| Subject | Azithromycin | Small molecule | 1000 mg | — |
| Subject | Chloroquine | Small molecule | 600 mg | — |
| Subject | Mefloquine | Unknown | 1250 mg | — |